Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

被引:17
作者
Lee, Joon Kyu [1 ,2 ]
Lee, Kee Byoung [3 ]
Kim, Joong Il [4 ]
Park, Gun Tae [5 ]
Cho, Young Chang [1 ]
机构
[1] Konkuk Univ, Med Ctr, Dept Orthopaed Surg, 120-1 Neungdong Ro, Seoul 05030, South Korea
[2] Konkuk Univ, Sch Med, Res Inst Med Sci, 120-1 Neungdong Ro, Seoul 05030, South Korea
[3] Cheongju St Marys Hosp, Dept Orthopaed Surg, 173-19 Jusung Ro, Cheongju 28323, Chungcheongbuk, South Korea
[4] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Orthopaed Surg, 1 Singil Ro, Seoul 07741, South Korea
[5] Hallym Univ, Dept Orthopaed Surg, Sacred Heart Hosp, 22 Gwanpyeong Ro, Anyang Si 14068, Gyeonggi Do, South Korea
关键词
Deep vein thrombosis; Total knee arthroplasty; Anticoagulant agent; Low-molecular-weight-heparin; Risk factor; MAJOR ORTHOPEDIC-SURGERY; TOTAL HIP-ARTHROPLASTY; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; GENERAL-ANESTHESIA; ASIAN PATIENTS; THROMBOPROPHYLAXIS; FONDAPARINUX; REPLACEMENT; ENOXAPARIN;
D O I
10.1186/s43019-021-00109-z
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background With an increase in deep vein thrombosis (DVT) following total knee arthroplasty (TKA) in the Asian population, most surgeons today use a form of prophylactic anticoagulant agents in patients after TKA. Nevertheless, DVT occasionally develops even in these patients with prophylaxis. The purpose of this study was to identify the risk factors for DVT after TKA in cases of postoperative low-molecular-weight heparin (LMWH) use. Methods We designed a retrospective study with 103 patients who underwent primary TKA. From the second postoperative day, 60 mg of LMWH was subcutaneously injected into the patients daily. On the seventh postoperative day, patients had computed tomography angiography to check whether they had DVT. Regarding risk factors, we investigated patients' gender, age, surgical site (unilateral/bilateral), body mass index, method of anesthesia, preoperative hypertension, diabetes, hypercholesterolemia status, and prothrombin time/international normalized ratio from electronic medical records. We analyzed the statistical significance of these risk factors. Results Statistically significant factors in the single-variable analysis were surgical site (unilateral/bilateral), body mass index, preoperative hypertension status, and anesthesia method. Multiple logistic regression analysis with these factors revealed that the surgical site (unilateral/bilateral, p = 0.024) and anesthesia method (p = 0.039) were significant factors for the occurrence of postoperative DVT after TKA. Conclusions Patients undergoing simultaneous bilateral TKAs and patients undergoing TKA with general anesthesia need more attention regarding DVT even with chemoprophylaxis using LMWH after TKA.
引用
收藏
页数:7
相关论文
共 41 条
[1]   Current guidelines for total joint VTE prophylaxis DAWN OF A NEW DAY [J].
Barrack, R. L. .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2012, 94B (11) :3-7
[2]   Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry [J].
Beyer-Westendorf, J. ;
Luetzner, J. ;
Donath, L. ;
Radke, O. C. ;
Kuhlisch, E. ;
Hartmann, A. ;
Weiss, N. ;
Werth, S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) :2045-2052
[3]   Incidence of deep vein thrombosis before and after total knee arthroplasty without pharmacologic prophylaxis: a 128-row multidetector CT indirect venography study [J].
Chang, Moon Jong ;
Song, Min Kyu ;
Kyung, Min Gyu ;
Shin, Jae Hoon ;
Chang, Chong Bum ;
Kang, Seung-Baik .
BMC MUSCULOSKELETAL DISORDERS, 2018, 19
[4]   Is routine chemoprophylaxis necessary for prevention of venous thromboembolism following knee arthroplasty in a low incidence population? [J].
Cho, Kye-Youl ;
Kim, Kang-Il ;
Khurana, Sumit ;
Bae, Dae-Kyung ;
Jin, Wook .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2013, 133 (04) :551-559
[5]  
Chung Kyu Sung, 2018, Knee Surg Relat Res, V30, P247, DOI 10.5792/ksrr.17.092
[6]   Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis [J].
Clarke, MT ;
Green, JS ;
Harper, WM ;
Gregg, PJ .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1997, 79B (05) :787-791
[7]   Prevention of VTE in Orthopedic Surgery Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Falck-Ytter, Yngve ;
Francis, Charles W. ;
Johanson, Norman A. ;
Curley, Catherine ;
Dahl, Ola E. ;
Schulman, Sam ;
Ortel, Thomas L. ;
Pauker, Stephen G. ;
Colwell, Clifford W., Jr. .
CHEST, 2012, 141 (02) :E278S-E325S
[8]   Comparison of Clinical Outcome Between Simultaneous-Bilateral and Staged-Bilateral Total Knee Arthroplasty: A Systematic Review of Retrospective Studies [J].
Fu, Dong ;
Li, Guodong ;
Chen, Kai ;
Zeng, Hui ;
Zhang, Xiaolong ;
Cai, Zhengdong .
JOURNAL OF ARTHROPLASTY, 2013, 28 (07) :1141-1147
[9]   Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial [J].
Fuji, Takeshi ;
Wang, Ching-Jen ;
Fujita, Satoru ;
Kawai, Yohko ;
Nakamura, Mashio ;
Kimura, Tetsuya ;
Ibusuki, Kei ;
Ushida, Hitoshi ;
Abe, Kenji ;
Tachibana, Shintaro .
THROMBOSIS RESEARCH, 2014, 134 (06) :1198-1204
[10]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S